Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Median effective dose of oxycelidine combined with propofol for painless fiberoptic bronchoscopy
ChiCTR2500095811Phase 4Not yet recruiting
- Sponsor
- Jiaxing Second Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxycodone and propofol in procedural pain, sponsored by Jiaxing Second Hospital. Primary endpoint: Movement response. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
oxycodonepropofol
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2500095811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095811.